Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

FDA: Docs should check on patients who got other drugs made by pharmacy in meningitis outbreak

FDA: Docs should check on patients who got other drugs made by pharmacy in meningitis outbreak | iNFOnews.ca
AppleMark

NEW YORK, N.Y. – Health officials have broadened their warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.

The Food and Drug Administration took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.

Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.

A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.

The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart transplant patients.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles